Agilon Health (NYSE:AGL) Trading Down 5.6% – Here’s What Happened

Agilon Health, Inc. (NYSE:AGLGet Free Report) shares traded down 5.6% during trading on Monday . The company traded as low as $87.45 and last traded at $87.35. 46,944 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 347,975 shares. The stock had previously closed at $92.54.

Wall Street Analyst Weigh In

Several brokerages recently commented on AGL. Benchmark reaffirmed a “buy” rating and set a $140.00 price objective (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agilon Health in a research note on Monday, August 24th. Wells Fargo & Company restated an “overweight” rating and issued a $146.00 price target (up from $141.00) on shares of Agilon Health in a report on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Finally, Citigroup upgraded Agilon Health from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $105.00 to $115.00 in a research report on Monday, August 10th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Agilon Health currently has a consensus rating of “Hold” and a consensus price target of $97.70.

View Our Latest Research Report on AGL

Agilon Health Trading Down 10.3%

The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The business’s fifty day moving average is $104.11 and its 200 day moving average is $63.89. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of -5.82 and a beta of 3.01.

Agilon Health (NYSE:AGLGet Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. Equities analysts predict that Agilon Health, Inc. will post -2.33 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of AGL. North Peak Capital Management LLC raised its position in Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after buying an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in Agilon Health by 196.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC boosted its position in Agilon Health by 1,346.6% during the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Agilon Health by 30.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock worth $5,523,000 after acquiring an additional 1,893,434 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Agilon Health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock worth $4,944,000 after acquiring an additional 35,054 shares in the last quarter.

Agilon Health Company Profile

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

Recommended Stories

Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.